Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Signs Global License for Ingenuity's IPA Software

NEW YORK (GenomeWeb News) - Ingenuity Systems today said that AstraZeneca has signed a global licensing agreement for its IPA pathway analysis platform.
Adriano Henney, director of discovery enabling capabilities and sciences at AstraZeneca, said in a statement that the company opted for IPA after testing several platforms across seven AstraZeneca sites in three countries for the past year.
According to Ingenuity, IPA supports data analysis for all high-throughput analysis platforms and can be used for toxicology, pharmacogenomics, and biomarker validation.
Financial terms were not disclosed. 

Filed under

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.